IP Library Granted Patent US 8,328,835
Granted Patent B2
US 8,328,835 · App. 12/329,872 · Granted Dec 11, 2012

System for operating and controlling a pneumatically driven vitrectomy probe

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,328,835
App. No.
12/329,872
Granted
Dec 11, 2012
Kind
B2
Abstract

A pneumatically driven vitrectomy probe system includes a movable member disposed within a cylinder to define an enclosed pressure chamber, which has an inlet and an outlet. A pressure transducer senses the pressure level within the enclosed pressure chamber, and a valve communicates pressurized air to the inlet of the enclosed pressure chamber based on the pressure level. A displacement device coupled to the movable member extends and retracts the movable member within the enclosed pressure chamber, to respectively increase and decrease the pressure level of pressurized air communicated via the chamber outlet. The pressurized air is communicated to enclosed volume within a pneumatically activated vitrectomy probe, which includes a hollow inner cutting member disposed within the hollow outer member. Upon extension of the displacement member, the resulting increase in pressure level of the pressurized air in the enclosed volume acts against the biasing spring to move the hollow inner cutting member, to cut vitreous material extending within the hollow outer member.

Claims (33)

1. A pneumatically driven vitrectomy probe system, comprising:

a cylinder having an open end in which a movable member is disposed so as to define an enclosed pressure chamber, the enclosed pressure chamber having an inlet and an outlet therein;

a pressure transducer in communication with the enclosed pressure chamber, for sensing the pressure level within the enclosed pressure chamber;

a valve having an outlet that is in communication with the inlet of the enclosed pressure chamber, wherein the valve communicates pressurized air from a pressurized air source to the inlet of enclosed pressure chamber based on the sensed pressure level;

a displacement device coupled to the movable member so as to extend and retract the movable member within the enclosed pressure chamber, to respectively increase and decrease the pressure level of the chamber and the pressurized air being communicated via the outlet of the enclosed pressure chamber; and

a pneumatically activated vitrectomy probe having an enclosed volume that is in communication with the outlet of the enclosed pressure chamber, the pneumatically activated vitrectomy probe further including a hollow outer member having a port near its distal end, and a hollow inner cutting member within the hollow outer member, which is biased by a spring away from said port, whereupon extension of the displacement member, the resulting increase in pressure within the enclosed volume acts against the biasing spring to move the hollow inner cutting member towards the port, to thereby cut vitreous material extending through the port in the hollow outer member.

2. The pneumatically driven vitrectomy probe system of claim 1 wherein the valve communicates pressurized air from a pressurized air source to the inlet of enclosed pressure chamber to maintain a pressure level that upon extension of the displacement device will cause the hollow inner cutting member to move against the biasing spring to a position in which the hollow inner cutting member closes off the port.

3. The pneumatically driven vitrectomy probe system of claim 1 wherein the operation of the displacement device causes the hollow inner cutting member to move back and forth relative to the port in a reciprocating manner.

4. The pneumatically driven vitrectomy probe system of claim 1 wherein the hollow outer member comprises a hollow sleeve having an opening port in the side of the hollow sleeve at its distal end portion, and the hollow inner cutting member is slidably disposed within the hollow sleeve and has a distal end defining a cutting edge, the hollow inner cutting member being movable towards the distal end of the hollow sleeve such that the cutting edge cuts any vitreous tissue disposed between the cutting edge and the opening port.

5. The pneumatically driven vitrectomy probe system of claim 4 , wherein the displacement device causes the hollow inner cutting member to be slidably displaced within the hollow sleeve in a reciprocating manner, such that the cutting member oscillates between a cutting position where the hollow inner cutting member closes off the opening port, and a position where the hollow inner cutting member is spaced apart from the opening port, to thereby provide for repetitive cutting action.

6. The pneumatically driven vitrectomy probe system of claim 1 wherein the movable member comprises a piston slidably disposed within the cylinder, and the displacement device comprises a crank shaft that is connected to the piston in a manner such that for every rotation of a drive motor the piston is extended and retracted within the enclosed pressure chamber, to thereby respectively increase and decrease the pressure within the enclosed pressure chamber and the enclosed volume in the pneumatically operated vitrectomy probe.

7. The pneumatically driven vitrectomy probe system of claim 1 , wherein the movable member comprises a movable diaphragm disposed within the cylinder, and the displacement device comprises a crank shaft that is connected to the movable diaphragm in a manner such that for every rotation of a drive motor the movable diaphragm is extendably displaced into the enclosed pressure chamber in the cylinder and then retracted, to thereby respectively increase and decrease the pressure within the enclosed pressure chamber and the enclosed volume in the pneumatically operated vitrectomy probe.

8. The pneumatically driven vitrectomy probe system of claim 1 wherein the movable member comprises a piston slidably disposed within the cylinder, and the displacement device comprises a drive solenoid coupled to the piston, which extends the piston within the enclosed pressure chamber when the solenoid is electrically activated and retracts the piston when the solenoid is deactivated, to thereby respectively increase and decrease the pressure within the enclosed pressure chamber and the enclosed volume in the pneumatically operated vitrectomy probe.

9. A pneumatically driven vitrectomy probe system, comprising:

a cylinder having an open end in which a piston is disposed so as to define an enclosed pressure chamber, the enclosed pressure chamber having an inlet for receiving pressurized air, and an outlet for communicating pressurized air to a pneumatically actuated vitrectomy probe;

a pressure transducer in communication with the enclosed pressure chamber, for sensing a pressure level within the enclosed pressure chamber;

a valve having an outlet that is in communication with the inlet to the enclosed pressure chamber, wherein the valve communicates pressurized air from a pressurized air source to the inlet of enclosed pressure chamber based on the pressure level;

a drive motor coupled to a crank shaft that is connected to the piston in a manner such that for every rotation of the motor the piston is extended and retracted within the enclosed pressure chamber, to thereby respectively increase and decrease the pressure level of the chamber and the pressurized air communicated via the outlet of the enclosed pressure chamber; and

a pneumatically activated vitrectomy probe having an enclosed volume that is in communication with the outlet of the enclosed pressure chamber, the pneumatically activated vitrectomy probe further including a hollow outer member having a port near its distal end, and a hollow inner cutting member within the hollow outer member, which is biased by a spring away from the port, whereupon extension of the piston, the resulting increase in pressure level within the enclosed volume acts against the biasing spring to move the hollow inner cutting member towards the port, to thereby cut vitreous material extending through the port in the hollow outer member.

10. The pneumatically driven vitrectomy probe system of claim 9 wherein the valve communicates pressurized air from a pressurized air source to the inlet of enclosed pressure chamber to maintain a pressure level that upon extension of the piston will cause the hollow inner cutting member to move against the biasing spring to a position in which the hollow inner cutting member closes off the port.

11. The pneumatically driven vitrectomy probe system of claim 9 wherein the continuous displacement and retraction of the piston causes the hollow inner cutting member to move back and forth relative to the port in a reciprocating manner.

12. The pneumatically driven vitrectomy probe system of claim 9 wherein the hollow outer member comprises a hollow sleeve having an opening port in the side of the hollow sleeve at its distal end portion, and the hollow inner cutting member is slidably disposed within the hollow sleeve and has a distal end defining a cutting edge, the hollow inner cutting member being movable towards the distal end of the hollow sleeve such that the cutting edge cuts any vitreous tissue disposed between the cutting edge and the opening port.

13. The pneumatically driven vitrectomy probe system of claim 12 , wherein the extension and retraction of the piston causes the hollow inner cutting member to be slidably displaced within the hollow sleeve in a reciprocating manner, such that the cutting member oscillates between a cutting position where the hollow inner cutting member closes off the opening port, and a position where the hollow inner cutting member is spaced apart from the opening port, to thereby provide for repetitive cutting action.

14. A pneumatically driven vitrectomy probe system, comprising:

a cylinder having an open end in which a movable diaphragm is disposed so as to define an enclosed pressure chamber, the enclosed pressure chamber having an inlet for receiving pressurized air, and an outlet for communicating pressurized air to a pneumatically actuated vitrectomy probe;

a pressure transducer in communication with the enclosed pressure chamber, for sensing a pressure level within the enclosed pressure chamber;

a valve having an outlet that is in communication with the inlet to the enclosed pressure chamber, wherein the Valve communicates pressurized air from a pressurized air source to the inlet of the enclosed pressure chamber based on the pressure level;

a drive motor coupled to a crank shaft that is connected to the movable diaphragm in a manner such that for every rotation of the motor the movable diaphragm is extendably displaced into the enclosed pressure chamber in the cylinder and then retracted, to thereby respectively increase and decrease the pressure within the enclosed pressure chamber and the enclosed volume in the pneumatically operated vitrectomy probe; and

a pneumatically activated vitrectomy probe having an enclosed volume that is in communication with the outlet of the enclosed pressure chamber, the pneumatically activated vitrectomy probe further including a hollow outer member having a port near its distal end, and a hollow inner cutting member within the hollow outer member, which is biased by a spring away from the port, whereupon extension of the movable diaphragm, the resulting increase in pressure level within the enclosed volume acts against the biasing spring to move the hollow inner cutting member towards the port, to thereby cut vitreous material extending through the port in the hollow outer member.

15. The pneumatically driven vitrectomy probe system of claim 14 wherein the valve communicates pressurized air from a pressurized air source to the inlet of enclosed pressure chamber to maintain a pressure level that upon extension of the diaphragm will cause the hollow inner cutting member to move against the biasing spring to a position in which the hollow inner cutting member closes off the port.

16. The pneumatically driven vitrectomy probe system of claim 14 wherein the continuous displacement and retraction of the diaphragm causes the hollow inner cutting member to move back and forth relative to the port in a reciprocating manner.

17. The pneumatically driven vitrectomy probe system of claim 14 wherein the hollow outer member comprises a hollow sleeve having an opening port in the side of the hollow sleeve at its distal end portion, and the hollow inner cutting member is slidably disposed within the hollow sleeve and has a distal end defining a cutting edge, the hollow inner cutting member being movable towards the distal end of the hollow sleeve such that the cutting edge cuts any vitreous tissue disposed between the cutting edge and the opening port.

18. The pneumatically driven vitrectomy probe system of claim 14 , wherein the extension and retraction of the movable diaphragm causes the hollow inner cutting member to be slidably displaced the within the hollow sleeve in a reciprocating manner, such that the cutting member oscillates between a cutting position where the hollow inner cutting member closes off the opening port, and a position where the hollow inner cutting member is spaced apart from the opening port, to thereby provide for repetitive cutting action.

Assignments (27)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 073637/0001 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
Reel/Frame 073654/0242 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
Reel/Frame 073637/0126 →
ASSIGNMENT OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (059913/0548) Recorded Aug 14, 2025
From: CITIBANK, N.A., AS RESIGNING AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT
Reel/Frame 072469/0091 →
PATENT SECURITY AGREEMENT Recorded Jul 1, 2025
From: BAUSCH & LOMB INCORPORATED; ALDEN OPTICAL LABORATORIES, INC.; BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 071773/0871 →
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
PATENT SECURITY AGREEMENT Recorded Oct 4, 2023
From: BAUSCH & LOMB INCORPORATED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 065120/0086 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 045444/0634) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; LABORATOIRE CHAUVIN S.A.S.; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 061872/0295 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 056811/0814) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061872/0669 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 059121/0001) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061873/0001 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 048556/0758) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH COMPANIES INC.; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 061872/0484 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 043251/0932) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; TECHNOLAS PERFECT VISION GMBH
Reel/Frame 061872/0099 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 045444/0299) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES; PF CONSUMER HEALTHCARE 1 LLC; LABORATOIRE CHAUVIN S.A.S.
Reel/Frame 061779/0001 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 031156/0508) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061778/0446 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 034749/0689) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; UNIVERSITY OF ROCHESTER
Reel/Frame 061778/0146 →
PATENT SECURITY AGREEMENT Recorded May 10, 2022
From: BAUSCH & LOMB INCORPORATED
To: CITIBANK, N.A. AS COLLATERAL AGENT
Reel/Frame 059913/0548 →
SECURITY AGREEMENT Recorded Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
SECURITY INTEREST Recorded Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH AMERICAS, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
SECURITY INTEREST Recorded Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
SECURITY INTEREST Recorded Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
SECURITY INTEREST Recorded Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
SECURITY INTEREST Recorded Jul 19, 2017
From: BAUSCH & LOMB INCORPORATED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043251/0932 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: BAUSCH & LOMB INCORPORATED
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031156/0508 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2013
From: CITIBANK N.A., AS ADMINISTRATIVE AGENT
To: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.); BAUSCH & LOMB INCORPORATED; ISTA PHARMACEUTICALS
Reel/Frame 030995/0444 →
SECURITY AGREEMENT Recorded Aug 6, 2012
From: BAUSCH & LOMB INCORPORATED; EYEONICS, INC.
To: CITIBANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 028728/0645 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2009
From: PERKINS, JAMES T.; MCCARY, BRIAN D.
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 022574/0207 →